title: [Drug-induced parkinsonism].
authors.forename: O S
authors.initials: OS
authors.lastname: Levin
authors.forename: N N
authors.initials: NN
authors.lastname: Shindriaeva
authors.forename: M A
authors.initials: MA
authors.lastname: Anikina
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects; D002936:Cinnarizine / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage / Q000009:adverse effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis*; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002121:Calcium Channel Blockers; D018492:Dopamine Antagonists; D002936:Cinnarizine; D014635:Valproic Acid; D008787:Metoclopramide